Tiefenbacher first-to-market launch: Rivaroxaban

Tiefenbacher Pharmaceuticals successfully prepares the launch of the anticoagulant Rivaroxaban across the European Union.  

We at Tiefenbacher Group strongly believe that our high-quality medicines should be affordable and available for all patients around the world – irrespective of their nationality or income. That´s why we are thrilled to share that we have successfully prepared a day one launch of the generic version of Rivaroxaban.

Generics are therapeutically equivalent to their branded counterparts with a lower price due to losing patent protection. The low cost of generic medications promotes patient affordability and contributes to lower per capita healthcare spending.

Rivaroxaban is an anticoagulant medication (blood thinner) used to treat and prevent blood clots. It makes blood flow through veins more easily by stopping a clotting factor called factor Xa from working. Rivaroxaban is also used to reduces the risk of stroke and systemic embolism with nonvalvular atrial fibrillation. The tablets are marketed by our cooperation partner, one of the biggest generic pharmaceutical companies in the world. Generally the new generic offers a more affordable alternative for the treatment of blood clotting. Thus making it easier for patients to access the treatment they need.

The product has been developed in TIEFENBACHER GROUP´s own laboratories in Hyderabad, India. Also it has already been launched in several European and international markets before. Overall, Tiefenbacher country scope covers about 70 countries around the world. Furthermore, the successful launch of this anticoagulant reflects our ongoing commitment to providing patients with high-quality, cost-effective medications. Undeniably it is a testament to the hard work and dedication of the team.

Finally, we are particularly excited about the positive impact this achievement will have. However we look forward to further market entries with high-quality medicines – with a patient-centred approach for better healthcare.

Tiefenbacher first-to-market launch: Rivaroxaban across Europe

TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes generic, value added, and innovative pharmaceuticals as well as medical devices and e-health-solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets.  

For more information about our finished dosage forms (FDF) including highly potent drugs and e-healthcare solutions, please contact us at  info@tiefenbacher.com or visit us on  www.tiefenbacher-pharmaceuticals.com

TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP, is a pharmaceutical full-service distributor for high-quality APIs and controlled substances with value-added services. We offer more than 600+ APIs (Human + Veterinary) in all fourteen ATC-Groups for safe, reliable pharmaceuticals.
For more information around our raw materials with best value seal (Better Access – Better Quality – Better Quality), please contact TIEFENBACHER API + INGREDIENTS: info-api@tiefenbacher.com or visit us on: www.tiefenbacher-api.com


Tiefenbacher Group welcomes new COO Sandip Tarate

Tiefenbacher Group welcomes new COO Sandip Tarate

We are pleased to welcome our new COO for AET Laboratories, Sandip Tarate, to Tiefenbacher Group.

Sandip has joined our site in Hyderabad, India, with 23+ years of extensive experience in the pharmaceutical sector. Furthermore, to induct and orient Sandip to Tiefenbacher family, our Managing Director Kristian Ruepp has visited our plant in Hyderabad. Therefore we ensure a great employee on-boarding experience.

Later, in view of Sandip’s first day, Kristian has hosted an inspiring town hall meeting underscoring the importance of the value system in our organization. We are energized about the path ahead for AET Laboratories, our customers, and our partners.

This is currently an exciting phase in our growth journey. The photo below shows the management team with our colleagues from the construction site extension in front of the newly built High Potent block. Undoubtedly this is proof that resilience and teamwork can work wonders!

The completion of the new building is the first step for Tiefenbacher Group to become a leading global developer and manufacturer of highly potent drugs for the treatment of cancer and other diseases. It follows our company´s strategy to make medicines more affordable, more available, and better than before.

Tiefenbacher Group welcomes new COO Sandip Tarate

TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP, is a pharmaceutical full-service distributor for high-quality APIs and controlled substances with value-added services. We offer more than 600+ APIs (Human + Veterinary) in all fourteen ATC-Groups for safe, reliable pharmaceuticals.
For more information around our raw materials with best value seal (Better Access – Better Quality – Better Quality), please contact TIEFENBACHER API + INGREDIENTS: info-api@tiefenbacher.com or visit us on: www.tiefenbacher-api.com


Featured Video Play Icon

Tiefenbacher Group raises awareness of autism

Tiefenbacher Group raises awareness of autism on today's World Autism Awareness Day.

Obviously the aim of World Autism Awareness Day is to draw attention to the needs and lifelong struggles of autistic people worldwide. It was founded on 2 April 2007 by the United Nations General Assembly. This year is being held across Europe under the motto “Not Invisible”. What does “not invisible” mean for autistic people?

Autism is often portrayed as an “invisible disability”. This “invisibility” repeatedly leads to marginalisation in society: parents who are punished with glances because their child breaks social rules. Children and young people who are accused of “not wanting to” and overlooked when it is a matter of “not being able to”. Adults who have to conform at all costs and go far beyond their own limits. Basically it is up to our society to make the needs of autistic people visible and to address them.

In light of this day, we also want to highlight that ADHD is often co-occurring with Autism Spectrum Disorder (ASD), affecting up to 40-50% of people with ASD. Generally with OYSTA, we aim to improve the health of people with these and other conditions. Through individualized dosing, safe medication management, and treatment support we will achieve this goal.

However, OYSTA is a cooperation between Tiefenbacher Group and OnDosis. Overall we want to revolutionize how patients take their medicines by combining pharmaceuticals and e-health technology. Thus every individual gets precisely the right dose of the medicine they need in a simpler, more comfortable way via a connected handheld device (under development) and digital solution.

Learn more about OYSTA

TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP, is a pharmaceutical full-service distributor for high-quality APIs and controlled substances with value-added services. We offer more than 600+ APIs (Human + Veterinary) in all fourteen ATC-Groups for safe, reliable pharmaceuticals.
For more information around our raw materials with best value seal (Better Access – Better Quality – Better Quality), please contact TIEFENBACHER API + INGREDIENTS: info-api@tiefenbacher.com or visit us on: www.tiefenbacher-api.com


Featured Video Play Icon

Tiefenbacher Group greetings from DCAT Week!

Today is the last day of one of the world´s most important pharma events – DCATWeek in New York City!

Our Tiefenbacher Group team sends greetings and their impressions of DCAT Week from the Big Apple! These were very successful days for Tiefenbacher Group. During these days we presented our latest product portfolio and innovations to our existing and potential new partners at the DCAT Week in New York City. We love the inspiring atmosphere here and look forward to exciting encounters and interesting discussions on this final day.

DCAT Week is the premier global event held annually in New York City. Especially for companies engaged in the Bio/Pharmaceutical Manufacturing Value Chain this event is important. Generally it is hosted by the Drug, Chemical & Associated Technologies Association (DCAT). Emphasising that it is a not-for-profit, member-supported, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies.

TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP, is a pharmaceutical full-service distributor for high-quality APIs and controlled substances with value-added services. We offer more than 600+ APIs (Human + Veterinary) in all fourteen ATC-Groups for safe, reliable pharmaceuticals.
For more information around our raw materials with best value seal (Better Access – Better Quality – Better Quality), please contact TIEFENBACHER API + INGREDIENTS: info-api@tiefenbacher.com or visit us on: www.tiefenbacher-api.com


Tiefenbacher Group awarded EcoVadis silver medal!

Tiefenbacher Group awarded EcoVadis silver medal!

We are excited to share that Tiefenbacher API + Ingredients has been awarded the EcoVadis Silver Medal!

EcoVadis is the world’s largest provider of business sustainability ratings. The EcoVadis sustainability assessment methodology is an evaluation of how well a company has integrated the principles of Sustainability/CSR into their business and management system. The Sustainability Scorecard illustrates performance across 21 indicators in four themes:

  • Environment
  • Labor and human rights
  • Ethics
  • Sustainable procurement

The award of the silver medal places our company among the top 15% of companies assessed by EcoVadis in the past 12 months – we even reached the 90th percentile! Thanks a lot to all colleagues at Tiefenbacher API + Ingredients who contribute to this advanced sustainability performance!

We, at TIEFENBACHER GROUP, know that our responsibility as a global healthcare company goes beyond medicine. We understand sustainability as behaving responsibly towards society and our planet – in our day-to-day work. That’s why we will continuously strive to achieve our sustainability goals!

Tiefenbacher Group awarded EcoVadis silver medal!

TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP, is a pharmaceutical full-service distributor for high-quality APIs and controlled substances with value-added services. We offer more than 600+ APIs (Human + Veterinary) in all fourteen ATC-Groups for safe, reliable pharmaceuticals.
For more information around our raw materials with best value seal (Better Access – Better Quality – Better Quality), please contact TIEFENBACHER API + INGREDIENTS: info-api@tiefenbacher.com or visit us on: www.tiefenbacher-api.com

About Tiefenbacher Group – Pioneering Healthcare since 1963 
Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDF) including highly potent drugs as well as medical devices and e-health-solutions. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products (including highly potent drugs) and e-health-solutions for global markets, please contact us by email atinfo@tiefenbacher.com or visit us on www.tiefenbachergroup.com


Tiefenbacher Group celebrares World Woman Day

Tiefenbacher Group celebrates International Women's Day

Today Tiefenbacher Group celebrates International Women's Day, that's why we would like to introduce you to two valuable female employees from our company.

Get to know the women who are working at Tiefenbacher Group for several years – and take a look at their interesting careers and experiences. They have managed to overcome challenges and successfully shaped their careers. Be inspired and use their tips to start a management career yourself.

That’s why we asked Stefanie Abt (Director of Business Development and Innovation and Director of Project Management) and Breshna Omar (Quality Assurance Manager) to tell us their story.

Steffanie Abt portfolio

Hello Stefanie, today is International Womens Day we would like to know more about you and your work for Tiefenbacher Group.

So “How did you begin your professional career?”

Stefanie: “I started my career 21 years ago as a Regulatory Affairs Trainee at Tiefenbacher, following my pharmacy studies. I enhanced my knowledge with a Master’s in Drug Regulatory Affairs and an Executive MBA. A standout experience was a six-month stint in 2006 at AET Laboratories in India, where I gained insights into pharmaceutical development and formed lasting international relationships, deepening my appreciation for Indian culture.” 

 

“What do you particularly like about your position?” 

Stefanie: “What I particularly appreciate about my role is the continuous stream of varied challenges, which keeps me learning new things daily. The blend of portfolio and project management allows me to accompany innovative project ideas from inception to patient delivery. This deep involvement in the entire product lifecycle, from initial concept to market entry, aligns with my passion for developing patient-centric therapies and reinforces my commitment to healthcare. The dynamic collaboration within our international company adds a rich, multicultural dimension to my work, making each day challenging, enjoyable, and constantly varied and enlightening.” 

 

In your opinion “What skills does a leader need? 

Stefanie: “Effective leadership blends resilience, clear communication, and the ability to inspire. Building trust and actively listening are crucial for strong team connections. In a diverse, supportive environment, it’s important to value every voice. Recognizing that we spend much time at work, making it enjoyable is key, as it boosts morale, creativity, and collaboration. A good sense of humor, particularly the ability to laugh at ourselves, is vital and a reminder that while we strive for excellence, the true goal is connection and enjoyment in what we do.” 

 

Could you tell us “What energizes you in your work life?”  

Stefanie: “In my work, the dynamic and ever-changing nature of our projects and challenges is incredibly energizing. The relentless pursuit of innovation in a rapidly evolving environment not only brings unique vibrancy but also a great deal of enjoyment to each day. Collaborating with my team to consistently devise innovative and practical solutions is deeply rewarding. Moreover, there’s a profound sense of fulfillment in seeing the company’s vision align with my own personal vision. This synergy significantly fuels my professional growth. Working in this fantastic company with such wonderful colleagues makes it all the more enjoyable. Helping to foster an environment that is appreciative, globally connected, and truly fun to be part of.” 

 

Finally we would like to know “What advice can you give to women aspiring to leadership positions?  

Stefanie: “My advice is to embrace lifelong learning, face challenges head-on, and nurture a robust professional network. Trust in your abilities and stay adaptable and optimistic, even when plans don’t unfold as expected. Understand that patience is key when progress seems slow. Authenticity is your greatest asset; use your unique skills and viewpoints to your advantage. Choose roles that align with your strengths and passions. Strive for a harmonious balance between your professional and personal life.

Remember, each path is distinct — discover what suits you best. Remain firm in your beliefs and values, while being open to self-reflection. Avoid to be swayed by the opinion of others who have walked different paths and instead embark on your own unique journey guided by your internal compass.

Breshna Omar portfolio

Today is International Womens Day Breshna and we are curious to know “How did you start your career at TG?”

Breshna:I started working at Tiefenbacher Group a bit more over 6 years ago. I applied for an open vacancy in Quality Assurance while I was studying for my state exams as a pharmacist and was looking for an apartment in Hamburg. I have very fond memories of my interview – AET took a chance on me by offering me the position even though I didn’t finish my exams yet. They believed in me and gave me even more motivation. The trust continued over the last years, as I could grow within the company and take over more and more responsibilities.”

 

And “What do you particularly like about your position?”

Breshna:Working in the Quality department demands unwavering dedication and attention to detail. It requires us to ensure the safety and effectiveness of medicines, safeguarding the health of millions. That’s why we cannot make compromises when it comes to quality. Every day, we’re driven by the knowledge that our work directly impacts lives, making a difference in the world. I love being part of this responsible department.”

 

Finally we would like to know “What future goals do you want to achieve or advance collectively at Tiefenbacher?”

Breshna: I want to realize my full potential at Tiefenbacher Group; continuously innovate products, services, and processes to stay competitive and meet evolving customer needs by delivering high-quality medicines. Foster a diverse and inclusive work environment where employees feel valued, respected, and empowered to contribute their best.

Because we are celebrating International Women’s Day today, I would like to take the opportunity to draw attention to equal rights for women in the workplace. On this day, we should inform and educate ourselves in order to understand the challenges women face in the workplace.”

We would like to take this opportunity to not only thank Stefanie and Breshna but all female employees of Tiefenbacher Group for their great commitment, everyday passion, and exceptionally good work! Happy International Women´s day!

Tiefenbacher Group celebrares World Woman Day

TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP, is a pharmaceutical full-service distributor for high-quality APIs and controlled substances with value-added services. We offer more than 600+ APIs (Human + Veterinary) in all fourteen ATC-Groups for safe, reliable pharmaceuticals.
For more information around our raw materials with best value seal (Better Access – Better Quality – Better Quality), please contact TIEFENBACHER API + INGREDIENTS: info-api@tiefenbacher.com or visit us on: www.tiefenbacher-api.com

About Tiefenbacher Group – Pioneering Healthcare since 1963 
Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDF) including highly potent drugs as well as medical devices and e-health-solutions. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products (including highly potent drugs) and e-health-solutions for global markets, please contact us by email atinfo@tiefenbacher.com or visit us on www.tiefenbachergroup.com


Tiefenbacher Group rare disease day

Tiefenbacher Group on awareness for rare disease day

Tiefenbacher Group draws attention to Rare Disease Day.

Today we are focusing on awareness and generating change for the 300 million people worldwide living with rare diseases. Treatment for many rare diseases is insufficient, that´s why we at Tiefenbacher Group are dedicated to protecting and improving lives through innovative healthcare solutions.

In the fight against rare diseases, we are committed to deliver high-quality pharmaceuticals which are better affordable, better available, and better than before. We are glad to offer a refined medication for Wilson Disease, Amifampridine for Lambert-Eaton Myasthenic Syndrome (LEMS) as well as a novel dosage form for a known medicine for Cystinosis – just to name a few of our innovative solutions.

Our culture of caring is essential to achieving our goal of significantly making a difference in the daily lives of people around the world. Therefore we will continue to focus on supporting initiatives like the rarediseaseday organisation that are in line with our values and beliefs.

Tiefenbacher Group rare disease day

TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP, is a pharmaceutical full-service distributor for high-quality APIs and controlled substances with value-added services. We offer more than 600+ APIs (Human + Veterinary) in all fourteen ATC-Groups for safe, reliable pharmaceuticals.
For more information around our raw materials with best value seal (Better Access – Better Quality – Better Quality), please contact TIEFENBACHER API + INGREDIENTS: info-api@tiefenbacher.com or visit us on: www.tiefenbacher-api.com

About Tiefenbacher Group – Pioneering Healthcare since 1963 
Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDF) including highly potent drugs as well as medical devices and e-health-solutions. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products (including highly potent drugs) and e-health-solutions for global markets, please contact us by email atinfo@tiefenbacher.com or visit us on www.tiefenbachergroup.com


Tiefenbacher Group supporting people in Ukraine by donating to Pharmacists without borders.

Tiefenbacher Group supports Pharmacists in Ukraine

Tiefenbacher Group supporting people in Ukraine by donating to Pharmacists without borders.

The 24 February 2024, marks the second anniversary of the brutal Russian war against a sovereign Ukraine. Its unbelievable that this war, and with it the suffering of the population in Ukraine, is still ongoing. We all at Tiefenbacher Group are far from forgetting this traumatic event and continue to have deepest respect for the courage and resilience of all Ukrainians who defend their democracy.

Our hearts and thoughts are with everyone affected by this war. We stand with all Ukrainians and continue to make significant donations to Apotheker ohne Grenzen Deutschland e.V. | Pharmacists without borders Germany to support emergency aid for children and families in Ukraine.

Our culture of caring is essential to achieving our goal of significantly making a difference in the daily lives of people around the world. Therefore we will continue to focus on supporting initiatives that are in line with our values and beliefs.

Tiefenbacher Group supporting people in Ukraine by donating to Pharmacists without borders.

TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP, is a pharmaceutical full-service distributor for high-quality APIs and controlled substances with value-added services. We offer more than 600+ APIs (Human + Veterinary) in all fourteen ATC-Groups for safe, reliable pharmaceuticals.
For more information around our raw materials with best value seal (Better Access – Better Quality – Better Quality), please contact TIEFENBACHER API + INGREDIENTS: info-api@tiefenbacher.com or visit us on: www.tiefenbacher-api.com


Tiefenbacher Group renovation

Tiefenbacher Group renovation of headquarters

Tiefenbacher Group keeping you updated on the ongoing renovation of our headquarters at the Port of Hamburg in Germany.

Tiefenbacher Group is happy to present some of the results of the remodelling and to bring even more changes to life.

In accordance with the modern design of the building, we are creating an innovative and state-of-the-art workspace that reflects our culture of entrepreneurship, professionalism and openness. The open-plan concept encourages creativity, collaboration and teamwork among our employees. Overall, the interior is airy, transparent and flooded with light.The modernisation also allowed us to integrate new branding elements into the workspace. We are convinced that the new premises directly on the banks of the river Elbe offer a great working environment that also promotes the growth and well-being of our employees.

The full modernisation of our headquarters is expected to be completed later this year.

Taking responsibility is part of the Tiefenbacher Group’s corporate culture. We want to create a positive working environment by improving our working environment to provide our team with the perfect place to work. Our culture of caring is essential to achieving our goal of making a difference in the daily lives of people and the planet around the world.

We will continue to improve our workplace to foster the best environment for our team to realise their full potential. We will keep you updated on the progress and look forward to welcoming you to our new offices soon!

Tiefenbacher Group renovation

TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP, is a pharmaceutical full-service distributor for high-quality APIs and controlled substances with value-added services. We offer more than 600+ APIs (Human + Veterinary) in all fourteen ATC-Groups for safe, reliable pharmaceuticals.
For more information around our raw materials with best value seal (Better Access – Better Quality – Better Quality), please contact TIEFENBACHER API + INGREDIENTS: info-api@tiefenbacher.com or visit us on: www.tiefenbacher-api.com

About Tiefenbacher Group – Pioneering Healthcare since 1963 
Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDF) including highly potent drugs as well as medical devices and e-health-solutions. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products (including highly potent drugs) and e-health-solutions for global markets, please contact us by email atinfo@tiefenbacher.com or visit us on www.tiefenbachergroup.com


Tiefenbacher API + Ingredients wishes a Happy Chinese New Year!

Tiefenbacher API + Ingredients wishes a Happy Chinese New Year!

The Chinese New Year is almost here.

On the 10th of February, people around the world celebrate the Chinese New Year. They honour this day with carnival events, family gatherings, parades, traditional food, fireworks and other festivities. It is one of the most important public holidays. Incidentally not only in China, but also in many other Asian countries that traditionally follow the lunar calendar. In Vietnam, Korea and Mongolia, for example, the new year is also celebrated on 10 February. Generally the Chinese New Year begins on the first day of the Chinese calendar and ends on the 15th day with the Yuanxiao Festival, the traditional lantern festival.

We at Tiefenbacher API + Ingredients greatly appreciate the diversity of our colleagues and look forward to celebrating their local traditions together. In the culture of our Chinese partners and colleagues, each year is associated with a particular animal of the Chinese zodiac. This year is the year of the dragon.

Tiefenbacher API + Ingredients is wishing you and your loved ones four seasons of peace and a flourishing year of the dragon.

Tiefenbacher API + Ingredients wishes a Happy Chinese New Year!

TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP, is a pharmaceutical full-service distributor for high-quality APIs and controlled substances with value-added services. We offer more than 600+ APIs (Human + Veterinary) in all fourteen ATC-Groups for safe, reliable pharmaceuticals.
For more information around our raw materials with best value seal (Better Access – Better Quality – Better Quality), please contact TIEFENBACHER API + INGREDIENTS: info-api@tiefenbacher.com or visit us on: www.tiefenbacher-api.com